Halyard Health (NYSE: HYH) is one of 80 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its rivals? We will compare Halyard Health to similar companies based on the strength of its risk, profitability, institutional ownership, valuation, analyst recommendations, earnings and dividends.
This table compares Halyard Health and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Halyard Health Competitors||-427.57%||-43.41%||-12.64%|
This is a breakdown of recent ratings and target prices for Halyard Health and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Halyard Health Competitors||211||1243||2716||95||2.63|
Halyard Health currently has a consensus target price of $44.00, suggesting a potential downside of 8.56%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.74%. Given Halyard Health’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Halyard Health has less favorable growth aspects than its rivals.
Risk & Volatility
Halyard Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Comparatively, Halyard Health’s rivals have a beta of 0.93, meaning that their average stock price is 7% less volatile than the S&P 500.
Institutional and Insider Ownership
90.3% of Halyard Health shares are held by institutional investors. Comparatively, 65.6% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 1.3% of Halyard Health shares are held by company insiders. Comparatively, 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Halyard Health and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Halyard Health||$1.59 billion||$39.80 million||40.44|
|Halyard Health Competitors||$975.11 million||$120.37 million||147.50|
Halyard Health has higher revenue, but lower earnings than its rivals. Halyard Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Halyard Health rivals beat Halyard Health on 7 of the 13 factors compared.
Halyard Health Company Profile
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
What are top analysts saying about Halyard Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halyard Health Inc. and related companies.